BMP-5 Polypeptide Injection for Rotator Cuff Tendon Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for rotator cuff conditions such as tendonitis and tears are inadequate in reversing tendon degeneration and enhancing healing and strength effectively.
Innovation Solution
The use of BMP-5 polypeptides and/or inhibitors of SIRT6, SIRT7, and HDAC10 polypeptide expression or activity, administered via injection or cells expressing BMP-5, to reduce or reverse tendon degeneration, enhance healing, and increase tendon strength in the rotator cuff region.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments are used for rotator cuff conditions, then the treatment process is simple and accessible, but the effectiveness in reversing tendon degeneration and enhancing healing is inadequate
Solution Approach 1:
The patent uses BMP-5 polypeptides as intermediary substances to mediate between the injection site and the tendon tissue, facilitating enhanced healing and strength. The BMP-5 acts as a biological mediator that stimulates tendon regeneration and repair processes, directly addressing the inadequacy of current treatments while maintaining a relatively simple injection-based administration route.
2Strength
If BMP-5 polypeptides are administered to treat rotator cuff conditions, then tendon healing and strength are enhanced, but the treatment cost and complexity increase
Solution Approach 1:
The patent employs parameter changes by administering specific concentrations and dosages of BMP-5 polypeptides to optimize tendon healing outcomes. By carefully controlling the parameters of BMP-5 administration (concentration, frequency, dosage), the treatment achieves enhanced tendon strength while managing the complexity associated with this advanced therapy approach.
3Reliability
If inhibitors of SIRT6, SIRT7, and HDAC10 are used to treat rotator cuff conditions, then tendon degeneration is reduced and healing is enhanced, but the treatment mechanism becomes more complex
Solution Approach 1:
The patent applies the extraction principle by specifically targeting and inhibiting certain enzymes (SIRT6, SIRT7, and HDAC10) that are involved in tendon degeneration. By extracting or removing the function of these specific enzymes through inhibition, the treatment achieves effective reversal of tendon degeneration while focusing on a specific molecular mechanism rather than addressing all possible pathways.
Data Source
AI summary
This document provides methods and materials related to treating rotator cuff conditions (e.g., rotator cuff tendonitis or rotator cuff injuries such as partial rotator cuff tears). For example, methods and materials for using BMP-5 polypeptides to treat rotator cuff conditions as well as methods and materials for using inhibitors of SIRT6, SIRT7, and/or HDAC10 polypeptide expression or activity to treat rotator cuff conditions are provided.